494 related articles for article (PubMed ID: 23280993)
21. Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13.
Fan M; Xu H; Wang L; Luo H; Zhu X; Cai P; Wei L; Lu L; Cao Y; Ye R; Fan W; Zhao BQ
Sci Rep; 2016 May; 6():25971. PubMed ID: 27181025
[TBL] [Abstract][Full Text] [Related]
22. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
[TBL] [Abstract][Full Text] [Related]
23. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
Guo Z; Yu S; Chen X; Zheng P; Hu T; Duan Z; Liu X; Liu Q; Ye R; Zhu W; Liu X
Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
[TBL] [Abstract][Full Text] [Related]
24. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
[TBL] [Abstract][Full Text] [Related]
25. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
26. YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-κB signaling pathways.
Pan XW; Wang MJ; Gong SS; Sun MH; Wang Y; Zhang YY; Li F; Yu BY; Kou JP
J Ethnopharmacol; 2020 Nov; 262():113161. PubMed ID: 32730882
[TBL] [Abstract][Full Text] [Related]
27. Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic stroke.
Houng AK; Wang D; Reed GL
Exp Neurol; 2014 May; 255():56-62. PubMed ID: 24556477
[TBL] [Abstract][Full Text] [Related]
28. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
[TBL] [Abstract][Full Text] [Related]
29. ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery.
Xu H; Cao Y; Yang X; Cai P; Kang L; Zhu X; Luo H; Lu L; Wei L; Bai X; Zhu Y; Zhao BQ; Fan W
Blood; 2017 Jul; 130(1):11-22. PubMed ID: 28428179
[TBL] [Abstract][Full Text] [Related]
30. Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke.
Strbian D; Karjalainen-Lindsberg ML; Kovanen PT; Tatlisumak T; Lindsberg PJ
Circulation; 2007 Jul; 116(4):411-8. PubMed ID: 17606844
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models.
Qiu L; Cai Y; Geng Y; Yao X; Wang L; Cao H; Zhang X; Wu Q; Kong D; Ding D; Shi Y; Wang Y; Wu J
Acta Biomater; 2022 Dec; 154():424-442. PubMed ID: 36367475
[TBL] [Abstract][Full Text] [Related]
32. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
Muhammad S; Planz O; Schwaninger M
Cerebrovasc Dis Extra; 2016; 6(2):50-9. PubMed ID: 27560521
[TBL] [Abstract][Full Text] [Related]
33. ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.
Denorme F; Langhauser F; Desender L; Vandenbulcke A; Rottensteiner H; Plaimauer B; François O; Andersson T; Deckmyn H; Scheiflinger F; Kleinschnitz C; Vanhoorelbeke K; De Meyer SF
Blood; 2016 May; 127(19):2337-45. PubMed ID: 26929275
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-10 effectively reduces infarct size in experimental stroke by enhancing fibrinolysis via a thrombin-activatable fibrinolysis inhibitor-mediated mechanism.
Orbe J; Barrenetxe J; Rodriguez JA; Vivien D; Orset C; Parks WC; Birkland TP; Serrano R; Purroy A; Martinez de Lizarrondo S; Angles-Cano E; Páramo JA
Circulation; 2011 Dec; 124(25):2909-19. PubMed ID: 22104553
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycemia promotes tissue plasminogen activator-induced hemorrhage by Increasing superoxide production.
Won SJ; Tang XN; Suh SW; Yenari MA; Swanson RA
Ann Neurol; 2011 Oct; 70(4):583-90. PubMed ID: 22002675
[TBL] [Abstract][Full Text] [Related]
36. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
Yang X; Chu H; Tang Y; Dong Q
Neuroscience; 2016 Aug; 329():54-65. PubMed ID: 27138645
[TBL] [Abstract][Full Text] [Related]
37. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
Allahtavakoli M; Amin F; Esmaeeli-Nadimi A; Shamsizadeh A; Kazemi-Arababadi M; Kennedy D
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
[TBL] [Abstract][Full Text] [Related]
38. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
[TBL] [Abstract][Full Text] [Related]
39. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.
Fan X; Jiang Y; Yu Z; Yuan J; Sun X; Xiang S; Lo EH; Wang X
Adv Pharmacol; 2014; 71():391-410. PubMed ID: 25307224
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke.
Wang R; Zhu Y; Liu Z; Chang L; Bai X; Kang L; Cao Y; Yang X; Yu H; Shi MJ; Hu Y; Fan W; Zhao BQ
Blood; 2021 Jul; 138(1):91-103. PubMed ID: 33881503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
